Hogan spokesman denies vaccine disparity between Convention Center, Six Flags

Baltimore Convention Center Field Hospital.jpg
Posted at 11:25 AM, Feb 17, 2021
and last updated 2021-02-17 11:55:22-05

BALTIMORE — Baltimore Mayor Brandon Scott called reports of an alleged disparity between vaccine distribution at the Baltimore Convention Center and Six Flags America, unacceptable.

"We need to have a more equitable distribution of the vaccine in the state of Maryland," Scott said to a reporter Wednesday.

The Mayor said he planned to address the issue with Governor Larry Hogan.

"This is something that we'll be going back and talking to the governor and his folks about, said Scott. "This is why we made the action we did with Johnson & Johnson. We feel like we see not just hear from folks across the state, republican and democrat, about how the vaccine is being distributed in the state isn't working for us."

Scott was referencing a long shot effort to get Johnson & Johnson to save a certain amount of their yet-to-be approved vaccine, being distributed at Emergent BioSolutions in East Baltimore.

READ MORE: Mayor Scott wants 300,000 COVID-19 vaccine doses from Johnson & Johnson to stay in the city

Soon after Scott's latest remarks, Michael Ricci, Governor Larry Hogan's Communications Director, disputed the report on Twitter saying there is "no need" for a conversation with the Governor.

Scott, Gov. Spokesman spar over vaccine disparity

Ricci says the Convention Center receives about 1,000 vaccines per day from the state while Six Flags gets 2,000.

He says the University of Maryland Medical System uses some of their vaccine allotment at the Convention Center, making it so the state doesn't have to provide any additional.

Ricci noted that thousands of more daily doses will be allocated to the city, beginning next week when the state opens its third mass vaccination site at M&T Bank Stadium.

As of Wednesday -- 55,859 people in Baltimore City have received their first dose of the COVID-19 vaccine. That equates to about 9.4 percent of the population. Less than half of that number has received the second dose.